Renaissance Lakewood, LLC

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Renaissance Lakewood, LLC - overview

Established

2000

Location

Lakewood, NJ, US

Primary Industry

Pharmaceuticals

About

Based in the US, Renaissance Lakewood, LLC specializes in the development and manufacturing of nasal spray and sterile injectable products, providing innovative solutions for pharmaceutical companies. Founded in 2000, Renaissance Lakewood, LLC operates from its headquarters in Lakewood, US, focusing on contract manufacturing for the pharmaceutical industry. The company has conducted one deal, with the most recent being in December 2025. Renaissance was acquired by LTS Lohmann Therapie-Systeme AG, which will enhance its pharmaceutical development capabilities.


Renaissance Lakewood LLC specializes in the development and manufacturing of nasal spray and sterile injectable products. The company provides a comprehensive range of services including formulation development, testing, and commercialization tailored to meet the needs of pharmaceutical companies. Their expertise spans nearly two decades, allowing them to address diverse therapeutic areas in markets like the United States, Europe, and Asia. They cater to clients from large pharmaceutical corporations to smaller biotech firms, focusing on innovative drug delivery solutions that improve patient experiences.


Their commitment to quality is reflected in their state-of-the-art facilities and adherence to cGMP standards. Renaissance Lakewood LLC generates revenue primarily through B2B transactions, offering contract development and manufacturing services for pharmaceutical products. Their revenue structure is based on service agreements covering initial formulation to commercial production. Clients typically engage Renaissance through project-based partnerships, with pricing structured around service complexity and volume.


Revenue is derived from both upfront fees and milestone payments linked to client project advancements. In December 2025, LTS Lohmann Therapie-Systeme AG acquired Renaissance Lakewood, LLC, which will enable LTS to expand its pharmaceutical development and manufacturing capabilities. The integration aims to leverage Renaissance's expertise and enhance product offerings in the market. Future strategies include designing new products and expanding into additional markets, with specific focus on Europe and Asia by 2026.


Current Investors

LTS Lohmann Therapie-Systeme AG, RoundTable Healthcare Partners

Primary Industry

Pharmaceuticals

Sub Industries

Pharmaceutical Research & Development

Website

www.renpharm.com/

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Renaissance Lakewood, LLC - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-on, Trade SaleCompletedRenaissance Lakewood, LLC-
BuyoutCompletedRenaissance Lakewood, LLC-

Displaying 1 - 2 of 2

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.